1-Methyl-1H-pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione

Catalog No. :
ACCIZR403
CAS No. :
83824-38-8
Molecular Formula :
C6H6N4O2
Molecular Weight :
166.14

IUPAC Name:1-methyl-1,4-dihydro-5H-pyrazolo[4,3-d]pyrimidine-5,7(6H)-dione

1-Methyl-1H-pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$131.00Login to see priceInquiryInquiry
100mg95%$190.00Login to see priceInquiryInquiry
250mg95%$263.00Login to see priceInquiryInquiry
1g95%$512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-1H-pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione
IUPAC Name1-methyl-1,4-dihydro-5H-pyrazolo[4,3-d]pyrimidine-5,7(6H)-dione
Molecular FormulaC6H6N4O2
Molecular Weight166.14
SMILESO=C1NC2=C(N(C)N=C2)C(N1)=O
InChI KeyOAXSBZVGKPGEDJ-UHFFFAOYSA-N
Synonym1-Methyl-1,4-dihydro-pyrazolo[4,3-d]pyrimidine-5,7-dione;1-METHYL-1H-PYRAZOLO[4,3-D]PYRIMIDINE-5,7-DIOL;1H-Pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione, 1-methyl-;1-Methyl-1H-pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione
CAS No.83824-38-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H320-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCIZR403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  2. Plus
  3. ACPDTZ185 route compound structure diagram
    ACPDTZ18592534-73-1 In Stock
  4. Then
  5. ACCIZR403 route product structure diagram
    ACCIZR40383824-38-8
Inquiry

2. ACCIZR403 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDTZ185 route compound structure diagram
    ACPDTZ18592534-73-1 In Stock
  2. Then
  3. ACCIZR403 route product structure diagram
    ACCIZR40383824-38-8
Inquiry

Comments (0)